These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 32552912)

  • 1. Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease.
    Shen R; Zhao X; He L; Ding Y; Xu W; Lin S; Fang S; Yang W; Sung K; Spencer B; Rissman RA; Lei M; Ding J; Wu C
    Transl Neurodegener; 2020 Jun; 9(1):26. PubMed ID: 32552912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuronal-specific isoform of BIN1 regulates β-secretase cleavage of APP and Aβ generation in a RIN3-dependent manner.
    Bhattacharyya R; Teves CAF; Long A; Hofert M; Tanzi RE
    Sci Rep; 2022 Mar; 12(1):3486. PubMed ID: 35241726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration.
    Xu W; Weissmiller AM; White JA; Fang F; Wang X; Wu Y; Pearn ML; Zhao X; Sawa M; Chen S; Gunawardena S; Ding J; Mobley WC; Wu C
    J Clin Invest; 2016 May; 126(5):1815-33. PubMed ID: 27064279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD2-associated protein (CD2AP) overexpression accelerates amyloid precursor protein (APP) transfer from early endosomes to the lysosomal degradation pathway.
    Furusawa K; Takasugi T; Chiu YW; Hori Y; Tomita T; Fukuda M; Hisanaga SI
    J Biol Chem; 2019 Jul; 294(28):10886-10899. PubMed ID: 31138646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIN3: a novel Rab5 GEF interacting with amphiphysin II involved in the early endocytic pathway.
    Kajiho H; Saito K; Tsujita K; Kontani K; Araki Y; Kurosu H; Katada T
    J Cell Sci; 2003 Oct; 116(Pt 20):4159-68. PubMed ID: 12972505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of RIN3 Gene in Alzheimer's Disease Pathogenesis: a Comprehensive Review.
    Meshref M; Ghaith HS; Hammad MA; Shalaby MMM; Ayasra F; Monib FA; Attia MS; Ebada MA; Elsayed H; Shalash A; Bahbah EI
    Mol Neurobiol; 2024 Jun; 61(6):3528-3544. PubMed ID: 37995081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.
    Xu W; Fang F; Ding J; Wu C
    Traffic; 2018 Apr; 19(4):253-262. PubMed ID: 29314494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of RIN3 as a guanine nucleotide exchange factor for the Rab5 subfamily GTPase Rab31.
    Kajiho H; Sakurai K; Minoda T; Yoshikawa M; Nakagawa S; Fukushima S; Kontani K; Katada T
    J Biol Chem; 2011 Jul; 286(27):24364-73. PubMed ID: 21586568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Recognition Preferences of the Three Src Homology 3 (SH3) Domains from the Adaptor CD2-associated Protein (CD2AP) and Direct Association with Ras and Rab Interactor 3 (RIN3).
    Rouka E; Simister PC; Janning M; Kumbrink J; Konstantinou T; Muniz JR; Joshi D; O'Reilly N; Volkmer R; Ritter B; Knapp S; von Delft F; Kirsch KH; Feller SM
    J Biol Chem; 2015 Oct; 290(42):25275-92. PubMed ID: 26296892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF.
    Jiang Y; Rigoglioso A; Peterhoff CM; Pawlik M; Sato Y; Bleiwas C; Stavrides P; Smiley JF; Ginsberg SD; Mathews PM; Levy E; Nixon RA
    Neurobiol Aging; 2016 Mar; 39():90-8. PubMed ID: 26923405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease.
    Kim S; Sato Y; Mohan PS; Peterhoff C; Pensalfini A; Rigoglioso A; Jiang Y; Nixon RA
    Mol Psychiatry; 2016 May; 21(5):707-16. PubMed ID: 26194181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
    Chen XQ; Salehi A; Pearn ML; Overk C; Nguyen PD; Kleschevnikov AM; Maccecchini M; Mobley WC
    Alzheimers Dement; 2021 Feb; 17(2):271-292. PubMed ID: 32975365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
    Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA
    J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bin1 and CD2AP polarise the endocytic generation of beta-amyloid.
    Ubelmann F; Burrinha T; Salavessa L; Gomes R; Ferreira C; Moreno N; Guimas Almeida C
    EMBO Rep; 2017 Jan; 18(1):102-122. PubMed ID: 27895104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.
    Kwart D; Gregg A; Scheckel C; Murphy EA; Paquet D; Duffield M; Fak J; Olsen O; Darnell RB; Tessier-Lavigne M
    Neuron; 2019 Oct; 104(2):256-270.e5. PubMed ID: 31416668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased neuronal expression of the early endosomal adaptor APPL1 leads to endosomal and synaptic dysfunction with cholinergic neurodegeneration.
    Jiang Y; Sachdeva K; Goulbourne CN; Berg MJ; Peddy J; Stavrides PH; Pensalfini A; Pawlik M; Whyte L; Balapal BS; Shivakumar S; Bleiwas C; Smiley JF; Mathews PM; Nixon RA
    bioRxiv; 2024 Sep; ():. PubMed ID: 39345644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease.
    Zhou Y; Hayashi I; Wong J; Tugusheva K; Renger JJ; Zerbinatti C
    PLoS One; 2014; 9(7):e103187. PubMed ID: 25051234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.